Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to collect real-world performance and safety data on the Penumbra System in a patient population with acute ischemic stroke (AIS)
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Penumbra Inc.
NCT07045987 · Acute Ischemic Stroke (AIS), Endovascular Thrombectomy, and more
NCT05585606 · Acute Ischemic Stroke (AIS)
NCT06115070 · Thrombosis, Acute Ischemic Stroke (AIS)
NCT06692101 · Acute Ischemic Stroke (AIS), Stroke-Associated Pneumonia (SAP), and more
Sir Charles Gairdner Hospital
Nedlands, Western Australia
CHU de Bordeaux - Hôpital Pellegrin
Bordeaux
CHU de Brest - Hôpital de la Cavale Blanche
Brest
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions